Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03206736 · ClinicalTrials.gov registry record · NA
Loop Duodenal Switch: Outcomes at One Year
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03206736: Clinical Trial NA study, sponsored by University of Nebraska.
NCT03206736 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03206736, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The biliopancreatic diversion and duodenal switch (BPD-DS) is an accepted and published type of bariatric surgery in the United States. The BPD-DS procedure produces the most weight loss of any bariatric surgery commonly performed but has the highest risk of malnutrition and gastrointestinal side effects. The loop duodenal switch (L-DS) is a bariatric surgery which has been modified from a biliopancreatic diversion and duodenal switch to maintain excellent weight loss while possibly reducing side effects. The surgical modifications in this procedure include reducing the number of intestinal reconnections from two to one and reducing the amount of small intestine which is bypassed. The L-DS operation is considered experimental by the American Society of Metabolic and Bariatric Surgery as long-term data in large numbers of patients is not available for weight loss or side effects. The purpose of this study is to examine weight loss and other outcomes in the L-DS operation up to 1 year after the procedure. Study participants will be seen in the clinic at 2 and 6 weeks, and 3, 6, 9, and 12 months per the bariatric surgery center protocol. As part of these normally scheduled visits, weight loss and health status will be recorded. Labs will be checked at 3, 6, and 12 months for nutritional status. A survey to reassess health-related quality of life and gastrointestinal symptoms will be performed at 3 months, 6 months and 12 months.
Primary Outcome
Excess weight loss at 1 year will be measured by comparing BMI at 1 year to the presurgical BMI. Body mass index (BMI) is calculated using the patient's height and weight. Height will be measured using a stadiometer and weight will be measured using the clinic's bariatric scale
Interventions
- OTHER Loop DS surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-08-09 |
| Est. Completion | 2020-05-07 |
| Phase | NA |
Why NCT03206736 stopped before completion
NCT03206736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Loop DS surgery is the first listed.
NCT03206736 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03206736 about?
NCT03206736 is a clinical study titled "Loop Duodenal Switch: Outcomes at One Year". The biliopancreatic diversion and duodenal switch (BPD-DS) is an accepted and published type of bariatric surgery in the United States. The BPD-DS procedure produces the most weight loss of any bariatric surgery commonly performed but has the highest risk of malnutrition and gastrointestinal side ef...
What is the current status of trial NCT03206736?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-08-09. Estimated completion is 2020-05-07.
What interventions are being tested in trial NCT03206736?
The interventions under investigation include: Loop DS surgery (OTHER).
Who is sponsoring clinical trial NCT03206736?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03206736's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI